Huzair, Farah; Papaioannou, Theo - In: Science and Public Policy 39 (2012) 4, pp. 500-512
Biobanks as collections of population level genetic and health data will be central to the innovation of new drugs and drug targets. The UK Biobank, funded by massive public and charitable investment, was created to store and manage the genetic and health data of over 500,000 people in the UK....